← Back to Search

Other

YR001 Ointment for Eczema

Phase 2
Recruiting
Research Sponsored by Hangzhou Yirui Pharmaceutical Technology Co., Ltd
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day1-day50

Summary

"This trial will test a new ointment called YR001 on adults with mild to moderate eczema to see if it is safe and how well the body absorbs it."

Who is the study for?
Adults with mild to moderate atopic dermatitis, commonly known as eczema, can participate in this trial. Specific eligibility criteria are not provided but typically include age range and health status requirements.
What is being tested?
The trial is testing YR001 ointment's safety, how well it's tolerated by patients, its absorption into the body (pharmacokinetics), and effectiveness in treating atopic dermatitis symptoms.
What are the potential side effects?
While specific side effects of YR001 ointment aren't listed here, common side effects for topical treatments may include skin irritation, redness, itching or burning sensation at the application site.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day1-day50
This trial's timeline: 3 weeks for screening, Varies for treatment, and day1-day50 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
The primary endpoint will be safety. Specifically, the primary endpoint will be the incidence of treatment-related AEs (TRAEs) through Day 50.
Secondary study objectives
Efficacy of YR001 Ointment
all treatment-emergents AEs

Trial Design

2Treatment groups
Experimental Treatment
Group I: Placebo doseExperimental Treatment2 Interventions
The intervention is Placebo on a range of body surface area for multiple topical administration
Group II: Active doseExperimental Treatment1 Intervention
The intervention is YR001 ointment on a range of body surface area for multiple topical administration

Find a Location

Who is running the clinical trial?

Hangzhou Yirui Pharmaceutical Technology Co., LtdLead Sponsor
1 Previous Clinical Trials
54 Total Patients Enrolled
~5 spots leftby Jan 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top